Thalassemia is thalassemia, a genetic disorder in which the patient eventually develops symptoms of hemolytic anemia due to an inherited genetic defect that results in impaired synthesis of red blood cell bead protein peptide chains. In clinical practice, screening for thalassemia includes routine blood tests and hemoglobin electrophoresis tests, both of which cost about$150 in total and may vary in price in different regions and different hospitals. The routine blood test will be able to find out if the patient has microcytic hypochromic anemia, because patients with thalassemia usually have microcytic hypochromic anemia, and if microcytic hypochromic anemia is found, further tests are needed to rule out thalassemia. The second screening test for thalassemia is the hemoglobin electrophoresis test. Through the hemoglobin electrophoresis test, it is possible to find out whether there are abnormal hemoglobin electrophoresis bands, and if there are abnormal hemoglobin concentration bands, it is necessary to further screen whether it is thalassemia. To confirm the diagnosis of thalassemia, the most effective way to confirm the diagnosis is to do the genetic test for thalassemia.